logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Corneagen Inc.


USPTO Granted Patents = 14


Trademarks = 8

Forward Citations = 2

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Jerry W Barker (10 out of 11 patents)

silverMedal Douglas C Drabble (9 out of 9 patents)

bronzeMedal Yousuf Khalifa (5 out of 5 patents)

4.  Timothy G Baldwin (4 out of 6 patents)

5.  Kevin Potts (3 out of 3 patents)

6.  Shigeru Kinoshita (2 out of 27 patents)

7.  Matthew Giegengack (2 out of 2 patents)

8.  Noriko Koizumi (2 out of 23 patents)

9.  Naoki Okumura (2 out of 18 patents)

10.  Peter R Andrews (2 out of 2 patents)

11.  Edward J Holland (2 out of 2 patents)

12.  Hiroatsu Hirano (1 out of 2 patents)

13.  Morio Ueno (1 out of 10 patents)

14.  Ursula Schloetzer-Schrehardt (1 out of 1 patent)

15.  Friedrich E Kruse (1 out of 1 patent)


14 patents:

1. 12453574 - Systems and methods for separating tissue in corneal transplant procedures (2025-10-28),
2. 12070414 - Medical tools for corneal tissue delivery (2024-08-27),
3. 12029642 - Systems and methods for corneal transplants (2024-07-09),
4. 12016970 - Systems and methods for preparing corneal tissue for implant (2024-06-25),
5. 11918456 - Devices and methods for implanting corneal tissue (2024-03-05),
6. 11730508 - Systems and methods for separating tissue in corneal transplant procedures (2023-08-22),
7. 11660233 - Systems and methods for tissue dissection in corneal transplants (2023-05-30),
8. 11624053 - Application of laminin to corneal endothelial cell culture (2023-04-11),
9. 11547778 - Systems and methods for preparing corneal tissue for implant (2023-01-10),
10. 11083565 - Systems and methods for corneal transplants (2021-08-10),
11. 10987212 - Devices and methods for implanting corneal tissue (2021-04-27),
12. 10908161 - Corneal endothelial cell marker (2021-02-02),
13. 10898383 - Systems and methods for tissue dissection in corneal transplants (2021-01-26),
14. 10864013 - Systems and methods for separating tissue in corneal transplant procedures (2020-12-15),
Company Overview
Corneagen Inc. is a biotechnology company based in Seattle, WA, specializing in the development of innovative solutions for ocular health. The organization focuses on advanced research in corneal tissue engineering and regenerative medicine, aiming to address unmet needs in eye care. By leveraging cutting-edge technologies, Corneagen is dedicated to improving treatment options and outcomes for patients with corneal diseases and injuries, contributing to the broader field of ophthalmology and vision restoration.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

14 Patents

#138 in Seattle, WA

#484 in Washington

#22,319 in US

#42,249 in the World

Seattle, WA (US)
Seattle, WA, United States of America

Corneagen Inc.

Forward Citations = 2

15 inventors:

goldMedal Jerry W Barker (10 out of 11 patents)

silverMedal Douglas C Drabble (9 out of 9 patents)

bronzeMedal Yousuf Khalifa (5 out of 5 patents)

4.  Timothy G Baldwin (4 out of 6 patents)

5.  Kevin Potts (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Corneagen Inc.. Retrieved from https://idiyas.com/company/corneagen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…